Just how many Americans are living with amyotrophic lateral sclerosis (ALS), often called Lou Gehrig's disease? A clearer picture is emerging thanks to new data from the federal government.
The Agency for Toxic Substances and Disease Registry (ATSDR), a part of the CDC, has released its second report from the National ALS Registry. This update provides crucial estimates on the prevalence of the neurodegenerative disease in the United States for the years 2012 and 2013.
Understanding the scope of ALS is the first step toward fighting it. This registry data helps researchers identify risk factors, plan clinical trials, and allocate resources more effectively. For public health officials and patient advocates, these numbers provide a foundation for building better support systems and care strategies.
The Medicup Perspective
For patients diagnosed with a progressive condition like ALS, managing care can be a significant challenge. Frequent travel to specialists' offices can become physically and emotionally taxing over time. This is where digital health platforms become essential.
Telehealth offers a vital lifeline, allowing patients to connect with their care teams for regular follow-ups, symptom management, and consultations from the comfort of home. By reducing the burden of travel, virtual care helps patients conserve energy and focus on their quality of life. The National ALS Registry itself is a powerful example of digital infrastructure in action, and at Medicup, we believe that extending that digital-first approach to direct patient care is the future of managing chronic and progressive diseases.
Source: [CDC Newsroom](https://tools.cdc.gov/api/embed/downloader/download.asp?m=132608&c=307939)